Yahoo
OTC Markets OTCPK - Delayed Quote USD

Ramsay Health Care Limited (RMYHY)

9.41 0.00 (0.00%)
At close: November 4 at 4:00:00 PM EST
Chart Range Bar
Loading chart for RMYHY
  • Previous Close 9.41
  • Open 9.78
  • Bid 9.39 x 40000
  • Ask 9.75 x 40000
  • Day's Range 9.78 - 9.78
  • 52 Week Range 5.08 - 9.91
  • Volume 3
  • Avg. Volume 34
  • Market Cap (intraday) 8.688B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 40.91
  • EPS (TTM) 0.23
  • Earnings Date --
  • Forward Dividend & Yield 0.16 (1.68%)
  • Ex-Dividend Date Sep 8, 2026
  • 1y Target Est --

Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.

www.ramsayhealth.com

91,400

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

RMYHY
70.66%
S&P/ASX 200 [XJO] (^AXJO)
4.03%

1-Year Return

RMYHY
89.14%
S&P/ASX 200 [XJO] (^AXJO)
2.64%

3-Year Return

RMYHY
28.86%
S&P/ASX 200 [XJO] (^AXJO)
29.55%

5-Year Return

RMYHY
26.62%
S&P/ASX 200 [XJO] (^AXJO)
21.57%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY23
Revenue 3.96B
Earnings 137M
Profit Margin 3.46%

Q3

FY22

Q4

FY22

Q2

FY23

0
1B
2B
3B
0.0%
1.0%
2.0%
3.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.77%

  • Return on Assets (ttm)

    3.18%

  • Return on Equity (ttm)

    5.69%

  • Revenue (ttm)

    18.65B

  • Net Income Avi to Common (ttm)

    313.5M

  • Diluted EPS (ttm)

    0.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    730.4M

  • Total Debt/Equity (mrq)

    196.67%

  • Levered Free Cash Flow (ttm)

    706.17M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: